Home · Health · Sep 29 archive
Eric Cantor Named PhRMA's New CEO
Developing
In Short: Former GOP House majority leader Eric Cantor will lead the pharmaceutical industry's top lobbying group, PhRMA.
PhRMA, the leading lobbying group for brand-name drug manufacturers, announced Tuesday that Eric Cantor will serve as its new CEO.
Cantor, a former Republican House majority leader, brings significant political experience to the role.
As CEO, Cantor will navigate increasing political pressure on drug prices and a growing populist sentiment from both major political parties.
PhRMA represents the interests of pharmaceutical companies in Washington, advocating for policies that support drug development and access.
What's still developing
- To read the rest of this story subscribe to STAT+.
- You may opt out of receiving STAT communications at any time.